MENU
INTS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Intensity Therapeutics (INTS) Ownership - Who owns Intensity Therapeutics?
Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers... Show more
Profile
Industry
N/A
Address
1 Enterprise Drive
Phone
+1 203 221-7381
Employees
17
Web
https://www.intensitytherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
28.08M
P/E Ratio
N/A
Total Cash
2.59M
Projected Growth
N/A
Total Debt
138K
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.17
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
INTS
Capitalization
28.1M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
2.59M
Total Cash/Share
0.17
Total Debt
138K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
2.92M
P/B Ratio
9.62
Cash Flow
N/A
Earnings
-1.17
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2K
Current Ratio
1.92
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-16.27M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-147.37
Shares Held By Institutions
3.97M
Shares Outstanding - Current
15.2M
Total Liabilities
1.87M
Total Volume MTD
N/A
Value
-1
Gain YTD
5.114
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
1 Enterprise Drive
Phone
+1 203 221-7381
Employees
17
Web
https://www.intensitytherapeutics.com